Your browser doesn't support javascript.
loading
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer.
Meijer, Dennie; Eppinga, Wietse S C; Mohede, Roos M; Vanneste, Ben G L; Meijnen, Philip; Meijer, Otto W M; Daniels, Laurien A; van den Bergh, Roderick C N; Lont, Anne P; Ettema, Rosemarijn H; Oudshoorn, Frederik H K; van Leeuwen, Pim J; van der Poel, Henk G; Donswijk, Maarten L; Oprea-Lager, Daniela E; Schaake, Eva E; Vis, André N.
Afiliação
  • Meijer D; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, Amsterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands. Electronic address: d.meijer2@amsterd
  • Eppinga WSC; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Mohede RM; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Vanneste BGL; Department of Radiation Oncology (MAASTRO), Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Meijnen P; Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Meijer OWM; Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Daniels LA; Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • van den Bergh RCN; Department of Urology, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands.
  • Lont AP; Department of Urology, Meander Medical Center, Amersfoort, The Netherlands.
  • Ettema RH; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Oudshoorn FHK; Department of Urology, Spaarne Gasthuis, Haarlem, The Netherlands.
  • van Leeuwen PJ; Department of Urology, The Netherlands Cancer Institute, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.
  • van der Poel HG; Department of Urology, The Netherlands Cancer Institute, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.
  • Donswijk ML; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Schaake EE; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Vis AN; Department of Urology, Prostate Cancer Network Netherlands, Amsterdam University Medical Center, Amsterdam, The Netherlands; Department of Urology, The Netherlands Cancer Institute, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.
Eur Urol Oncol ; 5(2): 146-152, 2022 04.
Article em En | MEDLINE | ID: mdl-35074282
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Glutamato Carboxipeptidase II / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Antígenos de Superfície Tipo de estudo: Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Glutamato Carboxipeptidase II / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Antígenos de Superfície Tipo de estudo: Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2022 Tipo de documento: Article